Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $63.4400 (-1.34%) ($62.9000 - $63.4400) on Fri. Dec. 9, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.18% (three month average) | RSI | 23 | Latest Price | $63.4400(-1.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -2.7% a day on average for past five trading days. | Weekly Trend | LGND declines -6.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(47%) IWN(47%) IWC(46%) IWO(45%) IBB(39%) | Factors Impacting LGND price | LGND will decline at least -2.09% in a week (0% probabilities). VXX(-21%) SHY(-14%) XBI(-9%) GLD(-8%) VCSH(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.09% (StdDev 4.18%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $54.84(-13.56%) | Resistance Level | $72.94 | 5 Day Moving Average | $66.05(-3.95%) | 10 Day Moving Average | $68.68(-7.63%) | 20 Day Moving Average | $72.94(-13.02%) | To recent high | -34.8% | To recent low | 2.6% | Market Cap | $1.02b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |